Physicians' perspectives on percutaneous left atrial appendage occlusion for patients with atrial fibrillation

被引:2
作者
Kir, Devika [1 ]
Van Houten, Holly K. [2 ]
Walvatne, Kelli N. [2 ]
Behnken, Emma M. [3 ]
Alkhouli, Mohamad Adnan [1 ]
Graff-Radford, Jonathan [4 ]
Melduni, Rowlens M. [1 ]
Gersh, Bernard J. [1 ]
Friedman, Paul A. [1 ]
Shah, Nilay D. [5 ]
Noseworthy, Peter A. [1 ,2 ]
Yao, Xiaoxi [1 ,2 ]
机构
[1] Mayo Clin, Dept Cardiovasc Dis, Rochester, MN 55905 USA
[2] Mayo Clin, Robert D & Patricia E Kern Ctr Sci Hlth Care Deliv, 200 First St SW, Rochester, MN 55905 USA
[3] Mayo Clin, Knowledge & Evaluat Res Unit, Rochester, MN 55905 USA
[4] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA
[5] Delta Airlines Inc, Atlanta, GA USA
基金
美国国家科学基金会; 美国国家卫生研究院; 美国医疗保健研究与质量局;
关键词
CLOSURE; OUTCOMES; RISK; CARE;
D O I
10.1016/j.ahj.2023.07.013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background There has been an increasing uptake of transcatheter left atrial appendage occlusion (LAAO) for stroke reduction in atrial fibrillation.Objectives To investigate the perceptions and approaches among a nationally representative sample of physicians.Methods Using the American Medical Association Physician Master file, we selected a random sample of 500 physicians from each of the specialties: general cardiologists, interventional cardiologists, electrophysiologists, and vascular neurologists. The participants received the survey by mail up to three times from November 9, 2021 to January 14, 2022. In addition to the questions about experiences, perceptions, and approaches, physicians were randomly assigned to 1 of the 4 versions of a patient vignette: white man, white woman, black man, and black woman, to investigate potential bias in decision-making.Results The top three reasons for considering LAAO were: a history of intracranial bleeding (94.3%), a history of major extracranial bleeding (91.8%), and gastrointestinal lesions (59.0%), whereas the top three reasons for withholding LAAO were: other indications for long-term oral anticoagulation (87.7%), a low bleeding risk (77.0%), and a low stroke risk (65.6%). For the reasons limiting recommendations for LAAO, 59.8% mentioned procedural risks, 42.6% mentioned "limiting efficacy data comparing LAAO to NOAC" and 32.8% mentioned "limited safety data comparing LAAO to NOAC." There was no difference in physicians' decision-making by patients' race, gender, or the concordance between patients' and physicians' race or gender.Conclusions In the first U.S. national physician survey of LAAO, individual physicians' perspectives varied greatly, which provided information that will help customize future educational activities for different audiences. Condensed Abstract Although diverse practice patterns of LAAO have been documented, little is known about the reasoning or perceptions that drive these variations. Unlike prior surveys that were directed to Centers that performed LAAO, the current survey obtained insights from individual physicians, not only those who perform the procedures (interventional cardiologists and electrophysiologists) but also those who are closely involved in the decision-making and referral process (general cardiologists and vascular neurologists). The findings identify key evidence gaps and help prioritize future studies to establish a consistent and evidence-based best practice for AF stroke prevention.
引用
收藏
页码:14 / 24
页数:11
相关论文
共 20 条
  • [1] Impact of atrial fibrillation on the risk of death
    Benjamin, EJ
    Wolf, PA
    D'Agostino, RB
    Silbershatz, H
    Kannel, WB
    Levy, D
    [J]. CIRCULATION, 1998, 98 (10) : 946 - 952
  • [2] AIM-AF: A Physician Survey in the United States and Europe
    Camm, A. John
    Blomstrom-Lundqvist, Carina
    Boriani, Giuseppe
    Goette, Andreas
    Kowey, Peter R.
    Merino, Jose L.
    Piccini, Jonathan P.
    Saksena, Sanjeev
    Reiffel, James A.
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (06):
  • [3] Worldwide Epidemiology of Atrial Fibrillation A Global Burden of Disease 2010 Study
    Chugh, Sumeet S.
    Havmoeller, Rasmus
    Narayanan, Kumar
    Singh, David
    Rienstra, Michiel
    Benjamin, Emelia J.
    Gillum, Richard F.
    Kim, Young-Hoon
    McAnulty, John H.
    Zheng, Zhi-Jie
    Forouzanfar, Mohammad H.
    Naghavi, Mohsen
    Mensah, George A.
    Ezzati, Majid
    Murray, Christopher J. L.
    [J]. CIRCULATION, 2014, 129 (08) : 837 - 847
  • [4] Effect of a Hospital and Postdischarge Quality Improvement Intervention on Clinical Outcomes and Quality of Care for Patients With Heart Failure With Reduced Ejection Fraction The CONNECT-HF Randomized Clinical Trial
    DeVore, Adam D.
    Granger, Bradi B.
    Fonarow, Gregg C.
    Al-Khalidi, Hussein R.
    Albert, Nancy M.
    Lewis, Eldrin F.
    Butler, Javed
    Pina, Ileana L.
    Allen, Larry A.
    Yancy, Clyde W.
    Cooper, Lauren B.
    Felker, G. Michael
    Kaltenbach, Lisa A.
    McRae, A. Thomas
    Lanfear, David E.
    Harrison, Robert W.
    Disch, Maghee
    Ariely, Dan
    Miller, Julie M.
    Granger, Christopher B.
    Hernandez, Adrian F.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (04): : 314 - 323
  • [5] Diagnosis and management of left atrial appendage thrombus in patients with atrial fibrillation undergoing cardioversion or percutaneous left atrial procedures: results of the European Heart Rhythm Association survey
    Farkowski, Michal M.
    Jubele, Kristine
    Marin, Francisco
    Gandjbakhch, Estelle
    Ptaszynski, Pawel
    Merino, Jose L.
    Lenarczyk, Radoslaw
    Potpara, Tatjana S.
    [J]. EUROPACE, 2020, 22 (01): : 162 - 169
  • [6] Antithrombotic Therapy After Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation
    Freeman, James, V
    Higgins, Angela Y.
    Wang, Yongfei
    Du, Chengan
    Friedman, Daniel J.
    Daimee, Usama A.
    Minges, Karl E.
    Pereira, Lucy
    Goldsweig, Andrew M.
    Price, Matthew J.
    Reddy, Vivek Y.
    Gibson, Douglas
    Doshi, Shephal K.
    Varosy, Paul D.
    Masoudi, Frederick A.
    Curtis, Jeptha P.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (18) : 1785 - 1798
  • [7] The NCDR Left Atrial Appendage Occlusion Registry
    Freeman, James, V
    Varosy, Paul
    Price, Matthew J.
    Slotwiner, David
    Kusumoto, Fred M.
    Rammohan, Chidambaram
    Kavinsky, Clifford J.
    Turi, Zoltan G.
    Akar, Joseph
    Koutras, Cristina
    Curtis, Jeptha P.
    Masoudi, Frederick A.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (13) : 1503 - 1518
  • [8] Kelly J, 2022, J AM COLL CARDIOL, V79, P909
  • [9] Left atrial appendage occlusion for stroke prevention in atrial fibrillation in Europe: results of the European Heart Rhythm Association survey
    Lip, Gregory Y. H.
    Dagres, Nikolaos
    Proclemer, Alessandro
    Svendsen, Jesper Hastrup
    Pison, Laurent
    Blomstrom-Lundqvist, Carina
    [J]. EUROPACE, 2013, 15 (01): : 141 - 143
  • [10] Percutaneous Left Atrial Appendage Occlusion in Comparison to Non-Vitamin K Antagonist Oral Anticoagulant Among Patients With Atrial Fibrillation
    Noseworthy, Peter A.
    Van Houten, Holly K.
    Krumholz, Harlan M.
    Kent, David M.
    Abraham, Neena S.
    Graff-Radford, Jonathan
    Alkhouli, Mohamad
    Henk, Henry J.
    Shah, Nilay D.
    Gersh, Bernard J.
    Friedman, Paul A.
    Holmes, David R., Jr.
    Yao, Xiaoxi
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (19):